Which returned more over the last year, FTXH or FXH?

In the year to Oct 28, 2026, with distributions reinvested, FTXH returned +47.9% and FXH +21.5%.

Which is cheaper, FTXH or FXH?

FTXH is cheaper, by 0.01 percentage points a year. That is about $1 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do FTXH and FXH overlap with the S&P 500?

By their latest filed holdings, 68% of FTXH and 59% of FXH by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

FTXH vs FXH: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, FTXH returned +47.9% to FXH's +21.5%; 30% of their weight is in the same names.

askIQ about this page

askIQ about FTXH and FXH

Net assets on Oct 27, 2026: $1.2bn for First Trust Nasdaq Pharmaceuticals ETF and $1.1bn for First Trust Health Care AlphaDEX Fund.

FTXH on its own →FXH on its own →

At a glance

+47.9%

FTXH total return, 1 year

+21.5%

FXH total return, 1 year

0.60%

FTXH expense ratio

0.61%

FXH expense ratio

Pair scorecard

FTXH costs 0.01 points a year less; their one-year returns differ by 26.4 points; FTXH is 1.1 times larger.

FTXH vs FXH: Differences, Returns & Fees
Measure	FTXH	FXH
Return
Measure	FTXH	FXH
Total return, 1 year	+47.9%	+21.5%
Benchmark
Measure	FTXH	FXH
What it tracks	Nasdaq US Smart Pharmaceuticals Index	StrataQuant Health Care Index
Cost and size
Measure	FTXH	FXH
Expense ratio	0.60%	0.61%
Net assets, as of Oct 27, 2026	$1.2bn	$1.1bn
Holdings
Measure	FTXH	FXH
Holdings in common	30%
Top ten holdings, share of the fund	54.8%	24.7%

Holdings in common uses holdings dated Oct 27, 2026. Method

Risk and return

Sep 30, 2016 to Oct 23, 2026 · 525 weekly returns

FTXH FXH

Return

Total return edge FTXH +145.2% +126.9%

Annualized edge FTXH (slight) +9.3% +8.5%

Price return edge FXH (slight) +116.4% +122.1%

Risk

Volatility edge Tie 18.3% 18.6%

Max drawdown edge FTXH (slight) −28.9% −29.5%

Risk-adjusted

Sharpe edge FTXH 0.44 0.40

Sortino edge FTXH 0.63 0.56

Calmar edge FTXH 0.32 0.29

Reading

FTXH returned more: +145.2% to +126.9%. FTXH and FXH swung about the same: 18.3% and 18.6%. FTXH fell slightly less at its worst: −28.9% to −29.5%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: FTXH vs FXH: Differences, Returns & Fees
Measure	FTXH	FXH	Edge	How it is measured
Return
Total return	+145.2%	+126.9%	FTXH	Price change plus distributions, reinvested.
Annualized	+9.3%	+8.5%	FTXH (slight)	Total return as a yearly rate.
Price return	+116.4%	+122.1%	FXH (slight)	Price change alone, distributions left out.
Risk
Volatility	18.3%	18.6%	Tie	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	12.8%	13.1%	FTXH (slight)	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−28.9%	−29.5%	FTXH (slight)	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.44	0.40	FTXH	Return above Treasury bills per unit of volatility.
Sortino	0.63	0.56	FTXH	Return above Treasury bills per unit of downside deviation.
Calmar	0.32	0.29	FTXH	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 525 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

30%

By the books each fund has filed, FTXH and FXH hold 30% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

50%

0 half 100%

half

30% in common

Positions both hold · largest shared weight first FTXH FXH

Exelixis, Inc. 2.50% 2.06%

Zoetis Inc. 3.49% 2.06%

Eli Lilly and Company 7.62% 2.04%

United Therapeutics Corporation 3.54% 2.01%

Regeneron Pharmaceuticals, Inc. 3.51% 1.98%

Amgen Inc. 3.58% 1.96%

Bristol-Myers Squibb Company 3.17% 1.82%

Halozyme Therapeutics, Inc. 1.77% 2.68%

Incyte Corporation 3.22% 1.77%

Jazz Pharmaceuticals Plc 2.26% 1.64%

Medpace Holdings, Inc. 1.60% 2.48%

AbbVie Inc. 7.68% 1.41%

Only in one fund ↓

Only in FTXH

Merck & Co., Inc. 6.60%

Gilead Sciences, Inc. 3.74%

Illumina, Inc. 2.22%

Charles River Laboratories International, Inc. 1.19%

Alnylam Pharmaceuticals, Inc. 1.12%

BioMarin Pharmaceutical Inc. 1.11%

Iovance Biotherapeutics, Inc. 0.85%

Moderna, Inc. 0.71%

Only in FXH

Centene Corporation 2.55%

The Cigna Group 2.53%

Globus Medical, Inc. (Class A) 2.49%

Zimmer Biomet Holdings, Inc. 2.49%

Universal Health Services, Inc. (Class B) 2.34%

Natera, Inc. 2.29%

Solventum Corporation 2.17%

DexCom, Inc. 2.10%

Check overlap with more funds →

Side by side

FTXH First Trust Nasdaq Pharmaceuticals ETF FXH First Trust Health Care AlphaDEX Fund

Where it sits Stock ETF Stock ETF

Issuer First Trust First Trust

What it is Tracks an index Tracks an index

Total return, 1 year +47.9% +21.5%

Expense ratio 0.60% 0.61%

Already in the S&P 500 68.0% 59.2%

Holdings 50 72

Net assets, as of Oct 27, 2026 $1.2bn $1.1bn

FTXH and FXH on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-5CA8156701

FTXH and FXH are built for the same job. How do they differ in cost, holdings and results?

What each follows. FTXH follows Nasdaq US Smart Pharmaceuticals Index and FXH follows StrataQuant Health Care Index.
Holdings in common. 30% of the weight is in the same securities (holdings dated Oct 27, 2026).
One-year total return. Over 1 year to Oct 28, 2026 FTXH returned +47.9% and FXH +21.5% with distributions reinvested, a gap of 26.4 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

FTXH

FTXH tracks an index. Over the year to Oct 28, 2026 it returned +47.9% with distributions reinvested. The prospectus expense ratio is 0.60% a year. By its holdings published by its issuer for Oct 27, 2026, 68% of the fund by weight is stocks the S&P 500 also holds, across 50 positions, with the top ten at 54.8%.

FXH

FXH tracks an index. Over the year to Oct 28, 2026 it returned +21.5% with distributions reinvested. The prospectus expense ratio is 0.61% a year. By its holdings published by its issuer for Oct 27, 2026, 59% of the fund by weight is stocks the S&P 500 also holds, across 72 positions, with the top ten at 24.7%.

Questions people ask

Which returned more over the last year, FTXH or FXH?: In the year to Oct 28, 2026, with distributions reinvested, FTXH returned +47.9% and FXH +21.5%.
Which is cheaper, FTXH or FXH?: FTXH is cheaper, by 0.01 percentage points a year. That is about $1 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do FTXH and FXH overlap with the S&P 500?: By their latest filed holdings, 68% of FTXH and 59% of FXH by weight is stocks the S&P 500 already holds.

Other comparisons

FTXH vs PPH FTXH vs IHF FTXH vs IHE FTXH vs IXJ FXH vs PPH FXH vs IHF FXH vs IHE FXH vs IXJ

Where to next

FTXH on its own →FXH on its own →Hold both: look the portfolio through →Rankings →FTXH dividend history →FTXH holdings →FXH dividend history →FXH holdings →Standards and sources →

Sources and dates

FTXH filings on SEC EDGAR ↗

FTXH prospectus with the expense ratio (SEC) ↗

First Trust page for FTXH ↗

FXH filings on SEC EDGAR ↗

FXH prospectus with the expense ratio (SEC) ↗

First Trust page for FXH ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, FTXH against FXH, data as of Oct 28, 2026. https://etfiq.com/compare/any/ftxh-vs-fxh

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.